Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 5
209
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Excelsanone, a new isoflavonoid from Erythrina excelsa (Fabaceae), with in vitro antioxidant and in vitro cytotoxic effects on prostate cancer cells lines

, , , , , & show all
Pages 659-667 | Received 30 Apr 2018, Accepted 28 Jun 2018, Published online: 08 Nov 2018
 

Abstract

A new isoflavonoid, excelsanone (2), was isolated from the ethyl acetate extract of Erythrina excelsa stem bark, together with three known compounds namely 6,8-diprenylgenistein (3), β-sitosterol (1) and sitosteryl-β-D-glucopyranoside (4). Their structures were elucidated using spectroscopic methods (HR-ESI-MS, NMR and IR) and by comparison with some literature data. The antioxidant activity of crude extracts and two isolated compounds was evaluated using free radical scavenging (DPPH) and Ferric Reducing Ability Power (FRAP) methods with catechin as standard. The results of the radical scavenging activity showed that excelsanone (2) has a moderate potential with an IC50 of 1.31 mg/ml. The cytotoxicity of compounds 2 and 3 as well as the ethyl acetate extract was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in two prostate cancer cell lines (DU145 and PC3). Excelsanone (2) induced a greater cytotoxicity in all tested cell lines, with a significant inhibition of DU145 cells growth in a concentration-dependent manner.

Acknowledgements

The authors are grateful to the Institute of Medical Research and Medicinal Plants Studies (IMPM) for providing some consumables. We also thank the pharmacognosy team of the University of Liège for undertaking the spectral analysis of compounds; and Professor Roman A. Blaheta (University Hospital Frankfurt) for his collaboration. We also gratefully acknowledge the financial support from Japan Society for the Promotion of Science Postdoctoral Fellowship awarded, through a travel grant (P16411) to Maurice D Awouafack at the Institute of Natural Medicine, University of Toyama.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

Some part of this work was supported by the Belgian National Fund for Scientific Research (FNRS).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.